Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 4:35 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
View Ticker Page (BPAX)
Results 1 - 10 of 19 : 12
Recs
rbcaps (< 20) Submitted: 3/09/07 2:44 AM : Start Price: $4.69 BPAX Score: 5.92
This company is making a drug to increase sex drives in women. An extremely large percentage of women have very low sex drives. This especially diminishes after menopause, and we have an aging population. This article http://www.nsti.org/press/PRsh...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
tweakie (< 20) Submitted: 2/05/08 2:46 AM : Start Price: $3.83 BPAX Score: -20.20
Why the heck did the CEO write to Adam Feuerstein??? Poor leadership.
Report this Post Replies: 1 | Reply | Permalink
BrianRuth (99.72) Submitted: 3/06/08 2:18 AM : Start Price: $5.75 BPAX Score: 5.19
I hope their sexygel works. I really do. But someone needs to be on the red thumb side of this stock and call (Penn & Teller) bull$#!*.
dstation (< 20) Submitted: 3/06/07 10:52 AM : Start Price: $4.40 BPAX Score: 9.57
One word--Libigel
tibber61 (86.21) Submitted: 3/28/07 9:28 PM : Start Price: $4.98 BPAX Score: 2.10
Unlike most bio firms, tech research companies focused on delivery systems seem to yield larger "hits" than "misses" by applying their discoveries over broader markets; most traditional biotechs seem to have too narrow a focus, leading to significant...
letsmakesomemone (< 20) Submitted: 7/28/08 1:31 PM : Start Price: $5.40 BPAX Score: -13.74
A biopharmaceutical company which develops hormone therapy products to treat men and women. It is also engaged in the development of its proprietary calcium phosphate nanotechnology for aesthetic medicine, novel vaccines and drug delivery.
EclecticRecluse (75.10) Submitted: 10/02/08 9:42 AM : Start Price: $4.38 BPAX Score: 5.44
Extremely High Price for Sales
pranilbalram (57.11) Submitted: 6/19/08 4:21 PM : Start Price: $5.45 BPAX Score: -9.06
Nice pipeline of products and exhibits the potential for a buyout. Very high debt ratio so the risk is high, however, strong working capital is present.
KBroodie1 (59.72) Submitted: 6/13/08 11:28 AM : Start Price: $5.60 BPAX Score: -9.21
They will improve overtime
Derrickmarshall (21.70) Submitted: 6/11/08 12:46 AM : Start Price: $4.31 BPAX Score: 10.12
Possible buyout target